BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:20 PM
 | 
Feb 20, 2007
 |  BC Extra  |  Clinical News

TiGenix's ChondroCelect meets Phase III endpoints

TiGenix (Haasrode, Belgium) said ChondroCelect met the primary endpoints of superior structural repair at 12 months and similar clinical outcome at 12 and...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >